HIV-1 Packing to Leave  by Cullen, Bryan R.
PreviewsHIV-1 Packing to LeaveBryan R. Cullen1,*
1Department of Molecular Genetics and Microbiology and Center for Virology, Duke University Medical Center, Durham, NC 27710, USA
*Correspondence: bryan.cullen@duke.edu
http://dx.doi.org/10.1016/j.cell.2014.11.008
HIV-1 virion assembly at the plasma membrane requires the selective recruitment of the viral RNA
genome into nascent viral particles while cellular transcripts are excluded. Kutluay et al. now
demonstrate that this is a two-step process in which Gag binds sequentially to different sites on
the viral genome.The final step in the life cycle of HIV-1 is
the assembly and release of progeny
virions by budding through the infected
cell plasma membrane (Sundquist and
Kra¨usslich, 2012). In this issue of Cell,
Kutluay et al. (2014) demonstrate that
the selective recruitment of the viral RNA
genome into virions—mediated by the
nucleocapsid (NC) domain of the viral
Gag polyprotein—involves the sequential
interaction of Gag with distinct genomic
RNA target sites, first in the infected cell
cytoplasm and then during the formation
of nascent viral particles at the plasma
membrane. Moreover, they also show
that transient binding of tRNAs to the ma-
trix (MA) domain of Gag plays a key role in
targeting Gag to the plasma membrane.
Analysis of the requirements for selec-
tive recruitment of an RNA into HIV-1
virions has previously identified a struc-
tured RNA element called ‘‘psi’’ (‘‘c’’),
located in the viral RNA 50 UTR, that
is selectively bound by NC and that
greatly facilitates genomic RNA pack-
aging (Clever et al., 1995; Lu et al.,
2011). However, the specificity of the
c:NC interaction is modest, and regions
outside of c have been proposed to also
facilitate genomic RNA packaging (Clever
et al., 1995; Richardson et al., 1993).
Moreover, while the initial interaction of
Gag monomers with the genomic RNA
occurs in the cytoplasm, the formation of
multimeric Gag complexes on the RNA
genome is dependent on localization to
the plasma membrane (Kutluay and Bien-
iasz, 2010).
To address which RNA:protein interac-
tions are involved in HIV-1 virion morpho-
genesis and whether these are modulated
in different cellular compartments, i.e., in
the cytoplasm, at the plasma membrane,
and inside HIV-1 virions, Kutluay et al.(2014) developed a remarkably efficient
variation on the previously published
‘‘photoreactive ribonucleoside-enhanced
crosslinking and immunoprecipitation’’
(PAR-CLIP) technique (Hafner et al.,
2010). PAR-CLIP relies on the incorpora-
tion of the photoreactive uridine analog
4-thiouridine into newly synthesized RNA
molecules, which confers efficient cross-
linking upon brief UV irradiation. Immuno-
precipitation, using antibodies specific for
Gag or for individual Gag domains, com-
bined with RNase treatment and deep
sequencing, then allowed a comprehen-
sive analysis of the RNA sequences
bound by these proteins.
Initial analysis gratifyingly reveals
strong binding of Gag to the c sequence
but also demonstrates strong binding to
the highly structured Rev response
element (RRE), which is required for HIV-
1 genomic RNA export to the cytoplasm
and serves as the binding site for the
HIV-1 Rev protein (Malim et al., 1989).
However, only 5% of RNA binding by
Gag involves viral transcripts and the
enrichment of viral RNA in the Gag-bound
versus total RNA pool is only 3- to 5-fold
relative to cellular RNAs, consistent with
the relatively low in vitro specificity of
Gag for c (Richardson et al., 1993). In
contrast, analysis of HIV-1 Gag binding
to RNA in immature virions gives a very
different picture. In particular, virion RNA
now contributed 50% of all Gag binding
sites and these were scattered across
the entire viral RNA genome. These bind-
ing sites are not, however, random and
in fact reveal a clear preference for
‘‘A’’-rich RNA sequences. Together,
these data reveal a two-step process
for virion RNA recruitment into virions.
In the cytoplasm, largely monomeric
Gag binds to both cellular RNAs and,Cell 159, Nwith modest specificity, to viral genomic
RNAs. Both cellular and viral RNA-bound
Gag molecules are then recruited to the
inner surface of the plasma membrane
(see below), where they have the potential
to serve as nucleation sites for Gag
multimerization. However, this process
requires the specific interaction of Gag
with A-rich sequences, scattered across
the viral genome, that are absent on
most cellular transcripts, thus explaining
the selectivity of genomic RNA pack-
aging.
While the NC domain of Gag is required
for genomic RNA recruitment into virions,
the amino-terminal MA domain is respon-
sible for the recruitment of Gag, and any
NC-bound RNA species, to the plasma
membrane (Chukkapalli et al., 2010).
Gag recruitment to the plasma mem-
brane requires the interaction of a highly
basic region (HBR) in MA with acidic
phospholipids, especially phosphatidyli-
nositol 4, 5-biphosphate [PtdIns(4,5)P2],
that are only present on the plasma mem-
brane. The HBR of MA has previously
been reported to also bind RNA nonspe-
cifically, and RNA had been proposed
to compete with membrane binding by
Gag, thus favoring Gag recruitment to
high-affinity binding sites on the plasma
membrane and blocking binding to
intracytoplasmic membranes (Chukka-
palli et al., 2013; Chukkapalli et al.,
2010). The data presented by Kutluay
et al. (2014) extend these earlier in vitro
observations by showing that MA indeed
binds RNA efficiently in infected cells.
More importantly, they identified the
bound RNAs as almost exclusively
tRNAs. The tRNAs bound to MA are,
however, released during virion forma-
tion, and it is therefore unlikely that MA
facilitates the virion incorporation of theovember 20, 2014 ª2014 Elsevier Inc. 975
Figure 1. RNA Binding to the HIV-1 Gag Protein
(A and B) Schematic representation of how tRNA binding to the Gag matrix (MA) domain in facilitates
recruitment of Gag to the plasma membrane (A) and the two step process by which the nucleocapsid
(NC) domain of Gag recruits HIV-1 genomic RNAs into newly formed virions (B). See text for detailed
discussion. CA, capsid domain of Gag; c, psi RNA packaging signal; RRE, Rev response element.lysine tRNA primer, especially as this
tRNA is not selectively bound by MA.
In conclusion, this report (Kutluay et al.,
2014) pulls together a number of previous
in vitro studies and substantially extends
these earlier data using highly sensitive
analytical techniques in HIV-1 infected
cells. These data reveal that two RNA
binding domains in Gag, located in MA
and NC, both play a key role in virion
formation (Figure 1). tRNA binding by
MAblocksGag recruitment to intracellular
membranes and instead promotes
Gag binding to the negatively charged
plasma membrane. Simultaneously, the976 Cell 159, November 20, 2014 ª2014 ElseNC domain initially recruits a mixture
of cellular and, preferentially, viral tran-
scripts to the plasma membrane, where
viral genomic RNAs are then incorporated
into virions due to selective binding of
NC to specific A-rich sequences on the
viral RNA genome during Gag multimeri-
zation (Figure 1).
One question left unresolved is whether
viral RNA binding sites for Gag other
than c, for example in the RRE, actually
promote the recruitment of cytoplasmic
RNA into virions, as also suggested by
earlier work (Richardson et al., 1993).
Kutluay et al. (2014) do show that deletionvier Inc.of the RRE, combined with substitution
by an unrelated nuclear RNA export signal
to allow the HIV-1 genomic RNA to reach
the cytoplasm, fails to uncover any role
for the RRE in viral RNA packaging when
the c element is intact. Nevertheless,
it remains possible that the RRE, or other
regions in the HIV-1 genome, are largely
redundant with c so that a role for
these RNA sequences in viral RNA pack-
aging would only be uncovered when c
is partially or fully inactivated.REFERENCES
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